Pancreatic Cancer Research

ResearcherMedical University of BiałystokNo recent work listed

Barbara Mroczko

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0002-4075-8479; OpenAlex author ID A5071565595.

Their work

Papers
6 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2018: 2 papers · 2019: 3 papers · 2020: 1 paper

Papers 6

  1. Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer. Last author DOI 10.3390/ijms21176193↗
  2. Novel potential biomarkers for pancreatic cancer - A systematic review. Last author DOI 10.1016/j.advms.2019.02.004↗
  3. Biochemical diagnostics of pancreatic cancer - Present and future. Last author DOI 10.1016/j.cca.2019.08.013↗
  4. Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC). Last author DOI 10.18632/oncotarget.26571↗
  5. The role of selected chemokines and their specific receptors in pancreatic cancer. Last author DOI 10.1177/1724600817753094↗
  6. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic… Last author DOI 10.20452/pamw.4307↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Marta Łukaszewicz-Zając · 5 shared papers, 2018–2020
  2. Ala Litman-Zawadzka · 3 shared papers, 2018–2020
  3. Wojciech Jelski · 1 shared paper, 2019
  4. Maciej Szmitkowski · 1 shared paper, 2019

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.